Prevalence and predictors of recurrence of major depressive disorder in the adult population

F Hardeveld, J Spijker, R De Graaf… - Acta Psychiatrica …, 2010 - Wiley Online Library
Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Prevalence and predictors of
recurrence of major depressive disorder in the adult population. Objective: Knowledge of the …

Pathological aspects of lipid peroxidation

A Negre-Salvayre, N Auge, V Ayala, H Basaga… - Free radical …, 2010 - Taylor & Francis
Lipid peroxidation (LPO) product accumulation in human tissues is a major cause of tissular
and cellular dysfunction that plays a major role in ageing and most age-related and …

[HTML][HTML] Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials

R Boussageon, I Supper, T Bejan-Angoulvant… - PLoS …, 2012 - journals.plos.org
Background The UK Prospective Diabetes Study showed that metformin decreases mortality
compared to diet alone in overweight patients with type 2 diabetes mellitus. Since then, it …

Insulin resistance syndrome in children

S Ten, N Maclaren - The Journal of Clinical Endocrinology & …, 2004 - academic.oup.com
The insulin resistance syndrome (syndrome X, metabolic syndrome) has become the major
health problem of our times. Associated obesity, dyslipidemia, atherosclerosis, hypertension …

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy

T Jiang, JT Yu, XC Zhu, HF Wang… - British journal of …, 2014 - Wiley Online Library
Background and Purpose Recent clinical trials report that metformin, an activator of AMP‐
activated protein kinase (AMPK) used to treat type 2 diabetes, significantly reduces the risk …

Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus

B Richter, E Bandeira‐Echtler… - Cochrane Database …, 2008 - cochranelibrary.com
Background In type 2 diabetes mellitus there is a progressive loss of beta‐cell function. One
new approach yielding promising results is the use of the orally active dipeptidyl peptidase …

Chemistry and biochemistry of type 2 diabetes

SA Ross, EA Gulve, M Wang - Chemical reviews, 2004 - ACS Publications
Today, we know that a primary metabolic action of insulin is to facilitate the postprandial
disposition of glucose via its actions on three key target tissues: suppression of glucose …

Metformin monotherapy for type 2 diabetes mellitus

A Saenz, I Fernandez‐Esteban… - Cochrane database …, 2005 - cochranelibrary.com
Background Metformin is an anti‐hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long‐term complications: micro‐(retinopathy …

The role of sulphonylureas in the management of type 2 diabetes mellitus

M Rendell - Drugs, 2004 - Springer
The sulphonylureas act by triggering insulin release from the pancreatic β cell. A specific site
on the adenosine triphosphate (ATP)-sensitive potassium channels is occupied by …

Should depression be managed as a chronic disease?

G Andrews - Bmj, 2001 - bmj.com
Methods I identified references to remission and relapse of depression during the writing up
of the Australian national mental health survey. References to long term prognosis came …